Welcome to the Starpharma Investor Centre

Starpharma Holdings Limited is an Australian stock exchange listed biotechnology company with products based on its dendrimer technology platform.

asx.jpg

View All
ASX Announcements

 

Update your
shareholder details

 

Download 
Annual Report

View 
Analyst coverage

 

Submit an Investor query

 

Register for email updates

Watch Starpharma's 2022 Annual General Meeting

  
   

Latest News & Announcements

Click here for news archive

Date of Starpharma’s Annual General Meeting 2023

Oct 2nd, 2023

Starpharma today announces, in accordance with ASX Listing Rule 3.13.1, that its 2023 Annual General Meeting (AGM) will be held at 2:00 p.m. (Melbourne time) on Wednesday, 29 November 2023.

Read More

DEP® irinotecan combination data to be presented at international oncology conference (ASX Announcement)

Sep 27th, 2023

Starpharma today announces the presentation of data that demonstrate the benefits of combining DEP® irinotecan with other important classes of anti-cancer therapies, including immuno-oncology (IO) agents, in models of human colorectal cancer.

Read More

 

Reports & Presentations

Click here for financial reports archive

Date of Starpharma’s Annual General Meeting 2023

Oct 2nd, 2023

Starpharma today announces, in accordance with ASX Listing Rule 3.13.1, that its 2023 Annual General Meeting (AGM) will be held at 2:00 p.m. (Melbourne time) on Wednesday, 29 November 2023.

Read More

DEP® irinotecan combination data to be presented at international oncology conference (ASX Announcement)

Sep 27th, 2023

Starpharma today announces the presentation of data that demonstrate the benefits of combining DEP® irinotecan with other important classes of anti-cancer therapies, including immuno-oncology (IO) agents, in models of human colorectal cancer.

Read More